According to Germany.
The German medicines regulator, the Paul Ehrlich Institute, has found 31 cases of cerebral sinus vein thrombosis (CSVT) among people who received AstraZeneca in Germany.
Almost all the cases are reportedly in younger and middle-aged women.
Covid: Germany limits use of AstraZeneca Covid jab for under-60s www.bbc.co.uk/news/world-europe-56580728
It would be interesting to know if, for example, Canada was able to give us similarly clear statistical evidence by sex.